These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 3887105)
41. Partial purification of a specific inhibitor of the insulin-like growth factors by reversed-phase high-performance liquid chromatography. Kuffer AD; Herington AC J Chromatogr; 1984 Dec; 336(1):87-92. PubMed ID: 6396314 [TBL] [Abstract][Full Text] [Related]
42. Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction. Daughaday WH; Parker KA; Borowsky S; Trivedi B; Kapadia M Endocrinology; 1982 Feb; 110(2):575-81. PubMed ID: 7035142 [TBL] [Abstract][Full Text] [Related]
43. Isolation and partial sequence analysis of rat basic somatomedin. Rubin JS; Mariz I; Jacobs JW; Daughaday WH; Bradshaw RA Endocrinology; 1982 Mar; 110(3):734-40. PubMed ID: 7056228 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. Daughaday WH; Mariz IK; Blethen SL J Clin Endocrinol Metab; 1980 Oct; 51(4):781-8. PubMed ID: 6998997 [No Abstract] [Full Text] [Related]
45. Interaction of somatomedin-C with an antibody directed against the synthetic C-peptide region of insulin-like growth factor-I. Hintz RL; Liu F; Marshall LB; Chang D J Clin Endocrinol Metab; 1980 Feb; 50(2):405-7. PubMed ID: 6153391 [TBL] [Abstract][Full Text] [Related]
46. Hormone ontogeny in the ovine fetus. XVI. Plasma immunoreactive somatomedin C/insulin-like growth factor I in the fetal and neonatal lamb and in the pregnant ewe. Van Vliet G; Styne DM; Kaplan SL; Grumbach MM Endocrinology; 1983 Nov; 113(5):1716-20. PubMed ID: 6354694 [TBL] [Abstract][Full Text] [Related]
47. A radioimmunoassay for insulin-like growth factor II specific for the C-peptide region. Hintz RL; Liu F J Clin Endocrinol Metab; 1982 Feb; 54(2):442-6. PubMed ID: 6172444 [TBL] [Abstract][Full Text] [Related]
48. Partial purification and characterization of somatomedin from sheep serum. Hossner KL; Davis SL; Powell C; Sasser RG Endocrinology; 1985 Apr; 116(4):1351-6. PubMed ID: 3971919 [TBL] [Abstract][Full Text] [Related]
50. Identification and high yield purification of insulin-like growth factors (nonsuppressible insulin-like activities and somatomedins) from human plasma by use of endogenous binding proteins. Ginsberg BH; Kahn CR; Roth J; Megyesi K; Baumann G J Clin Endocrinol Metab; 1979 Jan; 48(1):43-9. PubMed ID: 422704 [No Abstract] [Full Text] [Related]
51. An improved method for the purification of human insulin-like growth factors I and II. Petrides PE; Hintz RL; Bohlen P; Shively JE Endocrinology; 1986 May; 118(5):2034-8. PubMed ID: 3698905 [TBL] [Abstract][Full Text] [Related]
52. Synthetic insulin-like growth factor II. Li CH; Yamashiro D; Hammonds RG; Westphal M Biochem Biophys Res Commun; 1985 Mar; 127(2):420-4. PubMed ID: 3884009 [TBL] [Abstract][Full Text] [Related]
53. Affinity chromatography with amniotic fluid somatomedin binding protein in the purification of insulin-like growth factor I. PĆ³voa G; Wennberg G; Hall K Biochem Biophys Res Commun; 1986 Apr; 136(1):253-9. PubMed ID: 2423076 [TBL] [Abstract][Full Text] [Related]
54. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly. Rieu M; Girard F; Bricaire H; Binoux M J Clin Endocrinol Metab; 1982 Jul; 55(1):147-53. PubMed ID: 7042736 [No Abstract] [Full Text] [Related]
55. Radioreceptor-assayable somatomedins during pregnancy and their relationship to fetal growth. Sara VR; Gennser G; Persson PH J Dev Physiol; 1982 Jun; 4(3):187-93. PubMed ID: 6754800 [TBL] [Abstract][Full Text] [Related]
56. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum. Powell DR; Rosenfeld RG; Baker BK; Liu F; Hintz RL J Clin Endocrinol Metab; 1986 Nov; 63(5):1186-92. PubMed ID: 3760118 [TBL] [Abstract][Full Text] [Related]
57. Insulin-like growth factor I/somatomedin C (IGF-I/Sm C): comparison of natural, solid phase synthetic and recombinant DNA analog peptides in two radioligand assays. Schalch D; Reismann D; Emler C; Humbel R; Li CH; Peters M; Lau E Endocrinology; 1984 Dec; 115(6):2490-2. PubMed ID: 6389098 [TBL] [Abstract][Full Text] [Related]
58. Somatomedin-C is not increased in the serum of patients with amyotrophic lateral sclerosis. Denys EH; Pelle-Day G; Spencer EM Muscle Nerve; 1988 Sep; 11(9):1000-1. PubMed ID: 3173414 [No Abstract] [Full Text] [Related]
59. Growth-stimulating effects of somatomedin-/insulin-like peptides in Snell dwarf mice. van Buul-Offers S; Hoogerbrugge CM; Branger J; Feijlbrief M; Van den Brande JL Horm Res; 1988; 29(5-6):229-36. PubMed ID: 3220460 [TBL] [Abstract][Full Text] [Related]
60. Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors. Chochinov RH; Mariz IK; Daughaday WH Endocrinology; 1977 Feb; 100(2):549-56. PubMed ID: 188631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]